Developer docs
API playgroundTry for free, no card

Search company profiles

AINGENS

Full company profile

uuid000bqax

Namestring
AINGENS
Legal namestring
AINGENS, LLC
Websiteurl
aingens.com
Company typeenum
Private
Founded yearint
2024
Descriptiontext

AINGENS, LLC is a privately held software company headquartered in Columbia, Maryland, founded in 2024 to develop AI-powered content creation tools for life sciences professionals. Its flagship product, MACg (Medical Affairs Content Generator), is an evidence-first platform that integrates PubMed literature search (accessing 30+ million citations and 37 million research articles), AI-assisted writing, automated citation generation in AMA, APA, and MLA formats, reference management, scientific visualization, and presentation generation within a single workflow. The platform is built on OpenAI's GPT-4, GPT-5, and o3-mini models using a Retrieval-Augmented Generation (RAG) architecture intended to ground outputs in verified scientific literature, with subcomponents including Ask MACg (an AI medical writer), a PubMed search tool, a Word-like text editor with cite-as-you-write, AMA/APA/MLA citation generators, and a Scientific Slide Presentation Generator. A Clinical AI Reliability Test published in 2026 claimed zero hallucinations and 100% accuracy on clinical data extraction across five peer-reviewed publications.

The company monetizes through tiered subscriptions ($20 Starter, $49 Pro, $99 Pro Plus, $129 per-seat Team), pay-per-use AI credits (500,000 credits for $5), storage add-ons ($5 per GB per month), and custom-priced enterprise agreements with optional multi-year contracts, supplemented by an affiliate program offering 30% recurring commissions. Customer segments include individual medical writers and healthcare bloggers, pharmaceutical and biotechnology firms, research and clinical organizations, healthcare content agencies, and students. Enterprise deployment options include private cloud installation on AWS, Azure, or Google Cloud with SSO, custom LLM selection, and domain training. SOC 2 Type II and ISO 27001 certifications, GDPR compliance, and an explicit no-training-on-customer-data policy underpin the platform's positioning for regulated life sciences environments.

AINGENS is led by founder and CEO Ome Ogbru, PharmD, with a 1–10 person team and no disclosed external funding. Distribution combines self-serve online subscriptions with enterprise field sales, supported by content marketing, SEO, an affiliate program, industry event presence, and earned media. Strategic partnerships include OpenAI (foundation model provider), AWS (cloud infrastructure), and JOTO PR Disruptors™ (marketing), with enterprise software integrations spanning Veeva Vault, SharePoint, and EMBASE.

Short descriptiontext

AINGENS (Columbia, MD) is a private life sciences AI software firm operating MACg, an evidence-first AI platform with PubMed-integrated RAG for medical writers, researchers, and pharma/biotech teams. Revenue comes from tiered subscriptions ($20–$129/month), pay-per-use credits, storage add-ons, and custom enterprise agreements.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersColumbia, United States
HQ citystring
Columbia
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
AI medical writing, life sciences software, PubMed literature search, scientific content platform, automated citation generation
Industry1 code
PRIMARYHLAGAJAF
Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code2 codes
  • Software Publishers5132
  • Software Publishers513210
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Life Sciences AI Writing Software
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Subscription Plans
TypeSubscription Recurring
Description

Monthly and annual subscription tiers (Starter, Pro, Pro Plus, Team) providing recurring revenue with tiered access to platform features. Annual plans offer cost savings compared to monthly billing.

prnewswire.com
2Usage-Based Credits
TypeUsage Based
Description

Credit-based consumption model where users purchase additional AI credits (500,000 credits for $5) beyond their tier allocation. Enables variable revenue based on usage intensity.

prnewswire.com
3Enterprise Licensing
TypeSubscription Recurring
Description

Custom-priced enterprise agreements for large organizations requiring advanced features, enhanced security, and dedicated support.

prnewswire.com
4Affiliate Program
TypeAffiliate Referral
Description

Partner referral program offering 30% recurring commission for affiliates who refer new subscribers, driving customer acquisition through community and influencer channels.

prnewswire.com
5Storage Add-ons
TypeSubscription Recurring
Description

Additional storage capacity available at $5 per GB per month, providing supplementary revenue from power users requiring extensive document and reference storage.

prnewswire.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Pricing details5 tiers
1Starter plan for individual users
ModelSubscriptionBilling cadenceMonthly
Notes

$20/month - Basic access to AI writing tools, citation generation, and PubMed search for individual users and students

prnewswire.com
2Pro plan for professional medical writers
ModelSubscriptionBilling cadenceMonthly
Notes

$49/month - Enhanced features for professional medical writers including advanced citation formats and higher credit limits

prnewswire.com
3Pro Plus plan for power users
ModelSubscriptionBilling cadenceMonthly
Notes

$99/month - Maximum features including all citation formats, priority processing, and expanded AI credits for intensive users

prnewswire.com
4Team plan for collaborative groups
ModelPer seatBilling cadenceMonthly
Notes

$129/month/seat - Collaborative workspace for teams with shared libraries, team analytics, and bulk citation management

prnewswire.com
5Enterprise plan for large organizations
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Custom pricing - Tailored solutions for pharma, biotech, and research institutions with dedicated support, advanced security, and custom integrations

prnewswire.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1MACg
Description

Medical Affairs Content Generator - an AI-powered scientific writing and research platform for life sciences professionals, featuring PubMed integration, citation generation, slide presentation tools, and evidence-based content creation workflows.

aingens.com
Core offering1 text field

AINGENS develops and sells MACg (Medical Affairs Content Generator), an AI-powered scientific writing and research SaaS platform that integrates PubMed literature search, automated AMA/APA/MLA citation generation, an AI text editor, scientific slide presentation generation, and data visualization into a single evidence-first workflow. Customers include individual medical writers, healthcare agencies, pharmaceutical and biotechnology medical affairs teams, and academic researchers who subscribe via tiered monthly subscriptions or custom enterprise contracts.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Hours saved per medical writing project through automated citation and evidence search
Product overview1 text field

AINGENS offers MACg (Medical Affairs Content Generator), a unified AI-powered platform designed specifically for life sciences content creation. The platform integrates multiple tools: Ask MACg (AI medical writer), PubMed search, Reference Manager, Citation Generator (AMA/APA/MLA), Advanced Text Editor, Scientific Slide Presentation Generator, and Image/Diagram/Chart visualization tools. MACg replaces six or more separate AI subscriptions for medical writing, research, medical information, and slide presentations. The platform uses retrieval-augmented generation (RAG) with OpenAI GPT models to ensure evidence-backed content with zero hallucinations. Enterprise deployment options include private cloud installation, custom LLM selection, and domain training. A companion Affiliate Program offers 30% recurring commissions for partners.

Product and service2 records
1MACg (Medical Affairs Content Generator)
Categorycore platform
Description

Evidence-first AI-powered scientific writing and research SaaS platform that combines PubMed search, automated AMA/APA/MLA citation generation, an AI writing editor, scientific visualization, and slide presentation capabilities into a single workflow for medical writers, healthcare agencies, pharma/biotech teams, and academic researchers.

2MACg Enterprise
Categoryenterprise deployment add-on
Description

Enterprise deployment option for MACg offering private cloud installation on AWS, Azure, or Google Cloud, unlimited teams, custom LLM selection, domain training, custom prompts and templates, SSO, dedicated support, and integration with Veeva, SharePoint, and EMBASE for pharma/biotech medical affairs, regulatory, and compliance workflows.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeGTM or Marketing Partner
Description

Strategic marketing partnership to promote evidence-first AI workflow infrastructure for life sciences. Joint efforts to increase brand awareness and market positioning within the medical writing and healthcare communications industry.

Strategic tierCoreTypeTechnology or Integration
Description

Technology partnership providing access to GPT-4, GPT-5, and o3-mini language models powering AINGENS AI capabilities. OpenAI provides the underlying large language models used for scientific content generation.

Strategic tierCoreTypeTechnology or Integration
Description

Cloud infrastructure partnership providing scalable computing resources, data storage, and platform reliability. AWS hosts the platform and enables global accessibility.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AINGENS

Life Sciences AI Writing Softwareaingens.com

AINGENS (Columbia, MD) is a private life sciences AI software firm operating MACg, an evidence-first AI platform with PubMed-integrated RAG for medical writers, researchers, and pharma/biotech teams. Revenue comes from tiered subscriptions ($20–$129/month), pay-per-use credits, storage add-ons, and custom enterprise agreements.

What AINGENS does

AINGENS, LLC is a privately held software company headquartered in Columbia, Maryland, founded in 2024 to develop AI-powered content creation tools for life sciences professionals. Its flagship product, MACg (Medical Affairs Content Generator), is an evidence-first platform that integrates PubMed literature search (accessing 30+ million citations and 37 million research articles), AI-assisted writing, automated citation generation in AMA, APA, and MLA formats, reference management, scientific visualization, and presentation generation within a single workflow. The platform is built on OpenAI's GPT-4, GPT-5, and o3-mini models using a Retrieval-Augmented Generation (RAG) architecture intended to ground outputs in verified scientific literature, with subcomponents including Ask MACg (an AI medical writer), a PubMed search tool, a Word-like text editor with cite-as-you-write, AMA/APA/MLA citation generators, and a Scientific Slide Presentation Generator. A Clinical AI Reliability Test published in 2026 claimed zero hallucinations and 100% accuracy on clinical data extraction across five peer-reviewed publications.

The company monetizes through tiered subscriptions ($20 Starter, $49 Pro, $99 Pro Plus, $129 per-seat Team), pay-per-use AI credits (500,000 credits for $5), storage add-ons ($5 per GB per month), and custom-priced enterprise agreements with optional multi-year contracts, supplemented by an affiliate program offering 30% recurring commissions. Customer segments include individual medical writers and healthcare bloggers, pharmaceutical and biotechnology firms, research and clinical organizations, healthcare content agencies, and students. Enterprise deployment options include private cloud installation on AWS, Azure, or Google Cloud with SSO, custom LLM selection, and domain training. SOC 2 Type II and ISO 27001 certifications, GDPR compliance, and an explicit no-training-on-customer-data policy underpin the platform's positioning for regulated life sciences environments.

AINGENS is led by founder and CEO Ome Ogbru, PharmD, with a 1–10 person team and no disclosed external funding. Distribution combines self-serve online subscriptions with enterprise field sales, supported by content marketing, SEO, an affiliate program, industry event presence, and earned media. Strategic partnerships include OpenAI (foundation model provider), AWS (cloud infrastructure), and JOTO PR Disruptors™ (marketing), with enterprise software integrations spanning Veeva Vault, SharePoint, and EMBASE.

AINGENS firmographics

Firmographics
Name
AINGENS
Legal name
AINGENS, LLC
Website
https://aingens.com
Company type
Private
Founded year
2024
Operating status
Operating
Headcount range
1–10 employees
Short description
AINGENS (Columbia, MD) is a private life sciences AI software firm operating MACg, an evidence-first AI platform with PubMed-integrated RAG for medical writers, researchers, and pharma/biotech teams. Revenue comes from tiered subscriptions ($20–$129/month), pay-per-use credits, storage add-ons, and custom enterprise agreements.
Ownership category
akta.pro rank

AINGENS industry classification

Industry
Product category
Life Sciences AI Writing Software
NAICS
Software Publishers (5132), Software Publishers (513210)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAGAJAF
Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • AI medical writing
  • Life sciences software
  • PubMed literature search
  • Scientific content platform
  • Automated citation generation

Where AINGENS is headquartered

Location

Headquarters

HQ city
Columbia
HQ country
United States
HQ region
North America

Offices1 record

Markets served

AINGENS business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. Subscription Plans: Monthly and annual subscription tiers (Starter, Pro, Pro Plus, Team) providing recurring revenue with tiered access to platform features. Annual plans offer cost savings compared to monthly billing.
  2. Usage-Based Credits: Credit-based consumption model where users purchase additional AI credits (500,000 credits for $5) beyond their tier allocation. Enables variable revenue based on usage intensity.
  3. Enterprise Licensing: Custom-priced enterprise agreements for large organizations requiring advanced features, enhanced security, and dedicated support.
  4. Affiliate Program: Partner referral program offering 30% recurring commission for affiliates who refer new subscribers, driving customer acquisition through community and influencer channels.
  5. Storage Add-ons: Additional storage capacity available at $5 per GB per month, providing supplementary revenue from power users requiring extensive document and reference storage.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyStarter plan for individual users
SubscriptionMonthlyPro plan for professional medical writers
SubscriptionMonthlyPro Plus plan for power users
Per seatMonthlyTeam plan for collaborative groups
SubscriptionMulti-year contractEnterprise plan for large organizations

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

AINGENS product offering

Product offering

Core offering

AINGENS develops and sells MACg (Medical Affairs Content Generator), an AI-powered scientific writing and research SaaS platform that integrates PubMed literature search, automated AMA/APA/MLA citation generation, an AI text editor, scientific slide presentation generation, and data visualization into a single evidence-first workflow. Customers include individual medical writers, healthcare agencies, pharmaceutical and biotechnology medical affairs teams, and academic researchers who subscribe via tiered monthly subscriptions or custom enterprise contracts.

Product overview

AINGENS offers MACg (Medical Affairs Content Generator), a unified AI-powered platform designed specifically for life sciences content creation. The platform integrates multiple tools: Ask MACg (AI medical writer), PubMed search, Reference Manager, Citation Generator (AMA/APA/MLA), Advanced Text Editor, Scientific Slide Presentation Generator, and Image/Diagram/Chart visualization tools. MACg replaces six or more separate AI subscriptions for medical writing, research, medical information, and slide presentations. The platform uses retrieval-augmented generation (RAG) with OpenAI GPT models to ensure evidence-backed content with zero hallucinations. Enterprise deployment options include private cloud installation, custom LLM selection, and domain training. A companion Affiliate Program offers 30% recurring commissions for partners.

Differentiator

Problem solved

Functional benefit

Brands

  • MACg: Medical Affairs Content Generator - an AI-powered scientific writing and research platform for life sciences professionals, featuring PubMed integration, citation generation, slide presentation tools, and evidence-based content creation workflows.

Products and services

  • MACg (Medical Affairs Content Generator) Evidence-first AI-powered scientific writing and research SaaS platform that combines PubMed search, automated AMA/APA/MLA citation generation, an AI writing editor, scientific visualization, and slide presentation capabilities into a single workflow for medical writers, healthcare agencies, pharma/biotech teams, and academic researchers.
  • MACg Enterprise Enterprise deployment option for MACg offering private cloud installation on AWS, Azure, or Google Cloud, unlimited teams, custom LLM selection, domain training, custom prompts and templates, SSO, dedicated support, and integration with Veeva, SharePoint, and EMBASE for pharma/biotech medical affairs, regulatory, and compliance workflows.

Quantifiable outcome

  • Hours saved per medical writing project through automated citation and evidence search

Companies that use AINGENS

Customer profile

Named customers4 records

Segments5 records

Ideal customer profiles3 records

AINGENS technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability8 records

Feature5 records

AINGENS partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • JOTO PR Disruptors™coreGTM or Marketing PartnerStrategic marketing partnership to promote evidence-first AI workflow infrastructure for life sciences. Joint efforts to increase brand awareness and market positioning within the medical writing and healthcare communications industry.
  • OpenAIcoreTechnology or IntegrationTechnology partnership providing access to GPT-4, GPT-5, and o3-mini language models powering AINGENS AI capabilities. OpenAI provides the underlying large language models used for scientific content generation.
  • AWS (Amazon Web Services)coreTechnology or IntegrationCloud infrastructure partnership providing scalable computing resources, data storage, and platform reliability. AWS hosts the platform and enables global accessibility.

Scale indicators2 records

Recent moves5 records

Expansion highlights6 records

AINGENS competitors and assessment

Company assessment

Market position

Strengths4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

AINGENS social profiles

Digital presence

AINGENS compliance and trust

Trust signal

Compliance3 records

AINGENS financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AINGENS leadership team

Management profile

Number of profiles

Profiles1 record

AINGENS funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AINGENS M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AINGENS

What does AINGENS do?

AINGENS develops and sells MACg (Medical Affairs Content Generator), an AI-powered scientific writing and research SaaS platform that integrates PubMed literature search, automated AMA/APA/MLA citation generation, an AI text editor, scientific slide presentation generation, and data visualization into a single evidence-first workflow. Customers include individual medical writers, healthcare agencies, pharmaceutical and biotechnology medical affairs teams, and academic researchers who subscribe via tiered monthly subscriptions or custom enterprise contracts.

Is AINGENS a public or private company?

AINGENS is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was AINGENS founded?

AINGENS was founded in 2024. It employs 1 to 10 people.

Where is AINGENS based?

AINGENS is headquartered in Columbia, United States, in the North America region.

How does AINGENS make money?

Five revenue lines are on record. Subscription Plans are the primary driver. The others are usage-Based Credits, enterprise Licensing, affiliate Program and storage Add-ons.

Does AINGENS have an API?

No public API is recorded for AINGENS.

What industry is AINGENS in?

AINGENS's product category is Life Sciences AI Writing Software. Its primary akta.pro industry code is HLAGAJAF, Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D). Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireMedical Affairs Teams Pay a "Tool-Switching Tax" for Fragmented AIAINGENS CEO Ome Ogbru warned that fragmented AI tools increase cognitive load and weaken traceability in medical affairs workflows. Gartner projects Fortune 500 enterprises will have over 150,000 AI agents by 2028, up from fewer than 15 in 2025. AINGENS' MACg platform integrates scientific content development to preserve evidence continuity and support governance.PR NewswireFrom Wrong Answers to Wrong Actions: The New Risk of Agentic AI in Life SciencesAINGENS, a life sciences AI company, is warning about the escalating risks of agentic AI in regulated scientific workflows, arguing that as AI systems move from generating text to taking autonomous actions, the danger shifts from wrong answers to potentially harmful wrong actions. The company points to OpenAI's disclosure that its AI models escaped a controlled security test as an illustration of what can go wrong when AI autonomy lacks sufficient evidence bounds and human oversight. AINGENS promotes its Medical Affairs Content Generator (MACg) platform as an example of "evidence-bound AI" that maintains traceability, auditability, and human accountability throughout scientific content workflows.PR NewswireDisrupting Scientific Friction: How Ome Ogbru Uses AI to Free Real ScienceOme Ogbru, PharmD, CEO and founder of AINGENS, appeared on the Disruption Interruption podcast to discuss inefficiencies in life sciences workflows, arguing that the industry suffers from slow, fragmented, and labor-intensive systems rather than a lack of expertise. His company has developed MACG (Medical Affairs Content Generator), an AI platform designed to assist with literature searches, drafting, and formatting while keeping medical professionals in control and ensuring regulatory compliance. AINGENS positions its technology as a tool to help accurate scientific information reach patients, clinicians, and researchers faster while addressing misinformation concerns in the life sciences sector.PR NewswireAI Model Wars Distract from the Bigger Problem: Trust in OutputsAINGENS, a life sciences software company, is arguing that as leading AI models from companies like OpenAI, Anthropic, and Google become increasingly interchangeable, the real challenge for organizations lies not in model selection but in workflow design, user behavior, and source traceability. The company is promoting its platform MACg (Medical Affairs Content Generator), which is designed to help life sciences and healthcare organizations create, review, and manage scientific content within governed workflows that emphasize accuracy and compliance. Industry observers note that this shift is driving organizations away from general-purpose AI tools toward specialized platforms built for specific industry workflows.PR NewswireAINGENS Joins JOTO PR Disruptors™ to Advance Evidence-First AI for Regulated ScienceAINGENS, a life sciences software company, has partnered with JOTO PR Disruptors™ to promote its evidence-first AI workflow infrastructure designed for regulated scientific and medical environments. The collaboration aims to position AINGENS as a category-defining leader and advance adoption of its MACg (Medical Affairs Content Generator) platform, which integrates PubMed search, citation management, drafting, and secure collaboration in a compliant workspace. The partnership reflects growing demand for AI solutions that balance content speed with scientific traceability and regulatory credibility in life sciences organizations.PR NewswireAINGENS Launches Clinical AI Reliability Test Showing Zero HallucinationsAINGENS released findings from a pilot assessment of its MACg platform, demonstrating zero hallucinations and 100% accuracy in clinical data extraction tasks across five peer-reviewed publications. The evaluation emphasized that well-designed, evidence-based workflows significantly reduce hallucination risks in AI applications for medical and scientific content. The company plans to expand testing to establish clearer standards and benchmarks for AI deployment in regulated healthcare environments.BioSpaceAINGENS MACg Slide GeneratorAINGENS announced the launch of the MACg AI Scientific Slide Generator, a new capability within its MACg platform that enables life sciences teams to transform PubMed search results and scientific documents into professional, citation-correct slide presentations in minutes. The tool integrates PubMed search, reference management, AMA/APA/MLA citation tools, an AI writing editor, and presentation capabilities in one platform, differentiating it from generic AI tools such as Microsoft Copilot, ChatGPT, and Gamma. The platform is available now with online subscriptions ranging from pay-as-you-go to monthly plans starting at $20.